Literature DB >> 6199302

Bacterial adherence and glycocalyx formation in osteomyelitis experimentally induced with Staphylococcus aureus.

K J Mayberry-Carson, B Tober-Meyer, J K Smith, D W Lambe, J W Costerton.   

Abstract

A surgical procedure allowed the placement of a silicone rubber catheter in the marrow cavity of the tibia of a rabbit and also allowed the introduction of a sclerosing agent (sodium morrhuate) and cells of Staphylococcus aureus. Osteomyelitis developed in 60% of the animals so treated, and the infecting microorganism was recovered from the infected tibias of the animals that developed this disease. All blood cultures taken 24 h after the infection were negative for S. aureus. Radiological findings consisted of osteolytic changes, the occurrence of sequestration and periosteal reactions, and sclerosis in the infected bones. Sections of bone prepared for histological examination confirmed the diagnosis of osteomyelitis. Transmission and scanning electron microscopy of samples of bone marrow, bone chips, and the catheters taken from the infected tibiae revealed gram-positive cocci embedded in a very extensive matrix of ruthenium red-staining glycocalyx adhering to the bone and the implanted catheter. It is proposed that this extensive glycocalyx served a protective function for the bacteria and was important in bacterial adherence and thus played an important role in bacterial persistence and the development of osteomyelitis in these rabbits.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199302      PMCID: PMC264256          DOI: 10.1128/iai.43.3.825-833.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Ultrastructure of the capsule of Klebsiella pneumoniae and slime of Enterobacter aerogenes revealed by freeze etching.

Authors:  E L Springer; I L Roth
Journal:  Arch Mikrobiol       Date:  1973-11-19

2.  Ruthenium red and violet. I. Chemistry, purification, methods of use for electron microscopy and mechanism of action.

Authors:  J H Luft
Journal:  Anat Rec       Date:  1971-11

3.  Use of specific antibody to demonstrate glycocalyx, K99 pili, and the spatial relationships of K99+ enterotoxigenic Escherichia coli in the ileum of colostrum-fed calves.

Authors:  R Chan; S D Acres; J W Costerton
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

4.  A scanning and transmission electron microscopic study of the surfaces of intrauterine contraceptive devices.

Authors:  T J Marrie; J W Costerton
Journal:  Am J Obstet Gynecol       Date:  1983-06-15       Impact factor: 8.661

Review 5.  The bacterial glycocalyx in nature and disease.

Authors:  J W Costerton; R T Irvin; K J Cheng
Journal:  Annu Rev Microbiol       Date:  1981       Impact factor: 15.500

Review 6.  The role of bacterial surface structures in pathogenesis.

Authors:  J W Costerton; R T Irvin; K J Cheng
Journal:  Crit Rev Microbiol       Date:  1981       Impact factor: 7.624

7.  Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers.

Authors:  B J Wilkinson; P K Peterson; P G Quie
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

8.  Scanning electron microscopic study of uropathogen adherence to a plastic surface.

Authors:  T J Marrie; J W Costerton
Journal:  Appl Environ Microbiol       Date:  1983-03       Impact factor: 4.792

9.  Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis.

Authors:  J Lam; R Chan; K Lam; J W Costerton
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

10.  The fine structure of Chondrococcus columnaris. 3. The surface layers of Chondrococcus columnaris.

Authors:  J L Pate; E J Ordal
Journal:  J Cell Biol       Date:  1967-10       Impact factor: 10.539

View more
  26 in total

1.  Quorum sensing in Staphylococcus aureus biofilms.

Authors:  Jeremy M Yarwood; Douglas J Bartels; Esther M Volper; E Peter Greenberg
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

2.  Adjunctive therapies in the treatment of osteomyelitis.

Authors:  Robert C Fang; Robert D Galiano
Journal:  Semin Plast Surg       Date:  2009-05       Impact factor: 2.314

3.  Generation of virulence factor variants in Staphylococcus aureus biofilms.

Authors:  Jeremy M Yarwood; Kara M Paquette; Ilya B Tikh; Esther M Volper; E Peter Greenberg
Journal:  J Bacteriol       Date:  2007-08-03       Impact factor: 3.490

4.  Mode of growth of bacterial pathogens in chronic polymicrobial human osteomyelitis.

Authors:  T J Marrie; J W Costerton
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

5.  Effect of silver-doped phosphate-based glasses on bacterial biofilm growth.

Authors:  Sabeel P Valappil; Jonathan C Knowles; Michael Wilson
Journal:  Appl Environ Microbiol       Date:  2008-06-20       Impact factor: 4.792

6.  Staphylococcal exopolysaccharides inhibit lymphocyte proliferative responses by activation of monocyte prostaglandin production.

Authors:  R D Stout; K P Ferguson; Y N Li; D W Lambe
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

7.  A novel canine model of acute pyogenic spondylodiscitis.

Authors:  Wei-Hua Chen; Lei-Sheng Jiang; Li-Yang Dai
Journal:  Neurosurg Rev       Date:  2009-07-15       Impact factor: 3.042

8.  Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin.

Authors:  H Yasuda; Y Ajiki; T Koga; H Kawada; T Yokota
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

9.  Chronic staphylococcal osteomyelitis: a new experimental rat model.

Authors:  N Spagnolo; F Greco; A Rossi; L Ciolli; A Teti; P Posteraro
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

10.  Pigment gallstones form as a composite of bacterial microcolonies and pigment solids.

Authors:  L Stewart; A L Smith; C A Pellegrini; R W Motson; L W Way
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.